Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
Elutia Inc. (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix products, has announced it will release its second quarter 2024 financial results after market close on Wednesday, August 7, 2024. The company's management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
Investors can access the conference call through a webcast or by phone using the following details:
- U.S. Investors: 877-407-8029
- International Investors: 201-689-8029
- Conference ID: 13747696
A live and archived webcast of the event will be available on the 'Investors' section of the Elutia website at https://investors.elutia.com/.
Elutia Inc. (Nasdaq: ELUT), un pioniere nei prodotti a base di biomatrice farmaco-elutante, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 dopo la chiusura del mercato mercoledì, 7 agosto 2024. Il team di gestione dell'azienda ospiterà una conferenza telefonica e una trasmissione in diretta a partire dalle 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time dello stesso giorno.
Gli investitori possono accedere alla conferenza telefonica tramite web o telefono utilizzando i seguenti dettagli:
- Investitori U.S.: 877-407-8029
- Investitori Internazionali: 201-689-8029
- ID Conferenza: 13747696
Una trasmissione in diretta e registrata dell'evento sarà disponibile nella sezione 'Investitori' del sito web di Elutia all'indirizzo https://investors.elutia.com/.
Elutia Inc. (Nasdaq: ELUT), un pionero en productos de biomatriz con liberación de fármacos, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 después del cierre del mercado el miércoles 7 de agosto de 2024. El equipo de gestión de la empresa llevará a cabo una conferencia telefónica y una retransmisión en directo a partir de las 4:30 p.m. hora del Este / 1:30 p.m. hora del Pacífico el mismo día.
Los inversores pueden acceder a la conferencia telefónica a través de una retransmisión en directo o por teléfono utilizando los siguientes detalles:
- Inversores de EE.UU.: 877-407-8029
- Inversores Internacionales: 201-689-8029
- ID de la Conferencia: 13747696
Una retransmisión en vivo y grabada del evento estará disponible en la sección 'Inversores' del sitio web de Elutia en https://investors.elutia.com/.
엘루티아 주식회사(나스닥: ELUT)는 약물 방출 생체 매트릭스 제품의 선구자로서, 2024년 2분기 재무 결과를 2024년 8월 7일 수요일 시장 종료 후 공개할 것이라고 발표했습니다. 회사의 경영진은 같은 날 동부 표준시 오후 4시 30분 / 태평양 표준시 오후 1시 30분부터 전화 회의 및 웹세미나를 개최할 예정입니다.
투자자들은 다음 정보를 통해 웹세미나 또는 전화를 통해 회의에 참가할 수 있습니다:
- 미국 투자자: 877-407-8029
- 국제 투자자: 201-689-8029
- 회의 ID: 13747696
이벤트의 실시간 및 아카이브된 웹세미나는 엘루티아 웹사이트의 '투자자' 섹션에서 https://investors.elutia.com/를 통해 제공됩니다.
Elutia Inc. (Nasdaq: ELUT), pionnier dans les produits biomatriques à libération de médicaments, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 après la fermeture du marché le mercredi 7 août 2024. L'équipe de direction de l'entreprise animera une conférence téléphonique et une diffusion en direct à partir de 16h30, heure de l'Est / 13h30, heure du Pacifique, le même jour.
Les investisseurs peuvent accéder à la conférence téléphonique par le biais d'une diffusion en direct ou par téléphone en utilisant les informations suivantes :
- Investisseurs américains : 877-407-8029
- Investisseurs internationaux : 201-689-8029
- ID de la conférence : 13747696
Une diffusion en direct et enregistrée de l'événement sera disponible dans la section 'Investisseurs' du site web d'Elutia à l'adresse https://investors.elutia.com/.
Elutia Inc. (Nasdaq: ELUT), ein Pionier in der Entwicklung von medikamentenfreisetzenden Biomatrixprodukten, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 nach Börsenschluss am Mittwoch, den 7. August 2024 veröffentlichen wird. Das Managementteam des Unternehmens wird am selben Tag um 16:30 Uhr Eastern Time / 13:30 Uhr Pacific Time eine Telefonkonferenz und ein Webcast abhalten.
Investoren können auf die Telefonkonferenz über einen Webcast oder telefonisch über die folgenden Informationen zugreifen:
- US-Investoren: 877-407-8029
- Internationale Investoren: 201-689-8029
- Konferenz-ID: 13747696
Ein Live- und Archiv-Webcast der Veranstaltung wird im Bereich 'Investoren' der Website von Elutia unter https://investors.elutia.com/ verfügbar sein.
- None.
- None.
SILVER SPRING, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it will release its second quarter 2024 financial results after market close on Wednesday, August 7, 2024. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13747696
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at https://investors.elutia.com/.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
FAQ
When will Elutia (ELUT) release its Q2 2024 financial results?
What time is Elutia's (ELUT) Q2 2024 earnings call scheduled for?
How can investors access Elutia's (ELUT) Q2 2024 earnings call?
Where can I find the webcast for Elutia's (ELUT) Q2 2024 earnings call?
